TechConnect Innovation Program

Ultra-sensitive Biosensors for Clinical Diagnostics and Research

Graphene Frontiers, Pennsylvania, United States

TECHNOLOGY SUMMARY

Our innovation is a graphene biosensor that will revolutionize clinical diagnostics by shrinking lab-scale processes to automated chip-sized systems with unprecedented speed and sensitivity. The small size and sensitivity of the biosensor chips will enable multiplexing,testing for multiple biomarkers simultaneously, which will provide clinicians with comprehensive data for diagnosing patients.

Primary Application Area: Medical Devices

Technology Development Status: Prototype

Technology Readiness Level: TRL 3

FIGURES OF MERIT

Value Proposition: This IP is attractive to the market because the biosensors are highly sensitive, selective, allow multiplexing and testing for multiple biomarkers simultaneously, can be used at point of care and are cost effective. Highly sensitive and selective graphene-based biosensors will revolutionize point-of-care clinical diagnostics capabilities.

SHOWCASE SUMMARY

Organization Type: Early-stage Startup (Seed)

Showcase Booth #: 622

Website: graphenefrontiers.com

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date: Graphene Frontiers is proud to be supported by the National Science Foundation Awards:

NSF SBIR Phase I/IB
National Science Foundation IP - 1143163
02/01/2012-01/30/2013
Roll-to-roll Production of Uniform Graphene Films at Atmospheric Pressure and Low Temperature
Developing technology for the production of low-cost, high-quality and large-area graphene films for use in flexible electronics, chemical sensors, and other applications.
Award Amount: $180,000

NSF SBIR Phase II
National Science Foundation IIP-1330991
09/15/2013-08/31/2015
Roll-to-roll Production of Uniform Graphene Films at Atmospheric Pressure and Low Temperature
Developing technology for the production of low-cost, high-quality and large-area graphene films for use in flexible electronics, chemical sensors, and other applications.
Award Amount: $750,000

Furthermore, we hold an exclusive license to graphene technology
developed at the University of Pennsylvania. The lineage of support for our
core technology includes two NSF grants for work at the University of
Pennsylvania:
(1) NSF NSEC DMR08-32802. Nano/Bio Interface Center. This NSF support led to the development of the CVD graphene synthesis process that Graphene Frontiers is scaling and commercializing. Program manager: David Brandt.
(2) NSF DMR-0805136, Graphene- and Metal-Based Atomically Precise
Nanoelectronics. Understanding the growth mechanism of our process and the use of large-area CVD graphene material for the creation of nm-scale
graphene devices that are fabricated in a Transmission Electron Microscope and measured in situ. Program manager: Charles Ying.

Primary Sources of Funding: Angel, Friends, Family, Personal Savings, Federal Grant

Looking for: Both Funding and Development Partners